Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Reexamination Certificate
2005-04-26
2005-04-26
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
Reexamination Certificate
active
06884792
ABSTRACT:
The present invention is directed to novel pharmaceutical combinations including compositions and kits comprising bretylium as the active ingredient, as well as methods for preventing and/or treating conditions related to the cardiovascular system using such novel pharmaceutical combinations.
REFERENCES:
patent: 3038004 (1962-06-01), Copp et al.
patent: 3911125 (1975-10-01), Bacaner
patent: RE29618 (1978-04-01), Bacaner
patent: 4147768 (1979-04-01), Shaffer et al.
patent: 4849227 (1989-07-01), Cho
patent: 5036106 (1991-07-01), Bacaner
patent: 5288497 (1994-02-01), Stanley et al.
patent: 5288498 (1994-02-01), Stanley et al.
patent: 5733575 (1998-03-01), Mehra et al.
patent: 5750148 (1998-05-01), Maruyama et al.
patent: 5776501 (1998-07-01), Kokubo et al.
patent: 5814336 (1998-09-01), Kelm et al.
patent: 5914132 (1999-06-01), Kelm et al.
patent: 5980951 (1999-11-01), Gardner et al.
patent: 6482811 (2002-11-01), Bacaner et al.
patent: WO8705505 (1987-09-01), None
The Merck Manual of Diagnosis and Therapy, 14thEdition, published 1982 by Merck & Co., Inc., (NJ), pp 411-413, 429-437 an 532-535.*
Coetzee, C.J., et al., Liquid-Liquid Membrane Electrodes Based on Ion Association Extraction Systems, Analytical Chemistry, Jul. 1969, pp. 1128-1130.
Neubert, R., et al., Arzneimitteltransport durch kunstliche Lipoidmembranen, Pharmazie 42, 1987, pp. 309-311.
Bacaner, M., et al., Synergistic Action of Bretylium with Low Doses of Propranolol Renders the Canine Heart Virtually Invulnerable to Sustained Ventricular Fibrillation, Circulation Supplement Abstracts From the 60th Scientific Sessions, Oct. 1987, p. IV-111, Part II, vol. 76, No. 4, The American Heart Association, Inc., Dallas, Texas, U.S.A.
Neubert, R., et al., Influence of the ion-pair-formation on the pharmacokinetic properties of drugs, Pharmazie 9, Part 5, 1988.
Neubert, R., et al., Influence of ion-pair-formation on the pharmacokinetic properties of drugs, Pharmazie 12, Part 4, 1988.
Hartl, A., et al., Influence of the ion-pair-formation of bretylium and hexylsalicylic acid on their blood plasma levels in dogs, Pharmazie 45, Apr. 1990, p. 295.
Neubert, R., In vitro-Modellsysteme zur Beurteilung der Resorption aus dem Gastrointestinal-Trakt-Resorptionsmodelle, Die Pharmazie 45, Apr. 1990, pp. 233-237, No. 4.
Neubert, R., et al., Influence of lipophilic counter ions on the transport of ionizable hydrophilic drugs, Journal of Pharmacy & Pharmacology, Mar. 1991, pp. 204-206, vol. 43, No. 3.
Nuhn, P., et al., Biochemische Grundlagen zur Pharmazeutischen Chemie, Pharmazie 46, 1991, pp. 61-72, No. 1.
Amlacher, R., et al., Influence of Ion-pair Formation on the Pharmacokinetic Properties of Drugs, Pharmacokinetic Interactions of Bretylium and Hexylsalicyclic Acid in Rabbits, Journal of Pharmacy & Pharmacology, Nov. 1991, pp. 794-797, vol. 43, No. 11.
Neubert, R., et al., Ion Pair Approach of Bretylium, Die Pharmazeutische Industrie, 1992, pp. 370-372, vol. 54, No. 4.
Neubert, R., et al., Ion Pair Approach of Bretylium, Drugs Made in Germany, 1992, pp. 125-127, vol. 35, No. 4, Germany.
Bacaner Marvin B.
Kreevoy Maurice M.
Henley III Raymond J.
Senniger Powers
LandOfFree
Bretylium compositions and kits and their use in preventing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bretylium compositions and kits and their use in preventing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bretylium compositions and kits and their use in preventing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3440462